• Drug Watch
  • Digital Therapeutics
  • Diversity, Equity, Inclusion
  • Mental Health Awareness Month
  • Ethics
  • Cannabis
  • Climate Change
  • Psychedelics
  • Transcranial Magnetic Stimulation
  • COVID-19
  • Anxiety & Stress Disorders
  • Comorbidity
  • Cultural Psychiatry
  • Eating Disorders
  • Forensic Psychiatry
  • Geriatric Psychiatry
  • Integrative Psychiatry
  • Major Depressive Disorder
  • Mood Disorders
  • Addiction & Substance Use
  • Compulsive Disorders
  • Personality Disorders
  • Emergency Psychiatry
  • Psychopharmacology
  • Psychotherapy
  • PTSD
  • Psychosomatics
  • Neuropsychiatry
  • Schizophrenia/Psychosis
  • Suicide
  • Technology & Psychiatry
  • Tardive Dyskinesia
  • Bipolar Disorder
  • Special Populations
  • Sleep Disorders
  • Case Discussions
  • Child & Adolescent Psychiatry
  • ADHD
  • Major Depressive Disorder

Latest News

First Nontobacco Flavored E-Cigarette Products Authorized by the FDA

June 21st 2024

The FDA has authorized the marketing of 4 menthol-flavored e-cigarette products in the United States through the premarket tobacco product application pathway.

Chelsie Monroe, MSN, APN, PMHNP-BC, and Karl Doghramji, MD, FAASM, DFAPA
Clinical Pearls for the Management of Patients Suffering from Narcolepsy

June 21st 2024

Countertransference in Physician-Assisted Suicide: A Hypothesis

June 21st 2024

Investigating the Link Between Semaglutide and Suicidal Ideation

June 21st 2024

Questions About Angels

June 21st 2024

Continuing Medical Education: Earn Credits With Psychiatric Times
Conference Coverage: Dive deep into intricate aspects of psychiatry with these articles.
Free E-Newsletter! Receive timely news, insights, and resources for clinicians on the go.
Psychiatric Times, Tales From the Clinic: The Art of Psychiatry, Series Editor: Nidal Moukaddam, MD, PhD
June's Theme: Anxiety & Stress Disorders
Print Publication: peer-reviewed and practice-oriented. A monthly journal by and for mental health clinicians.

Special Reports

Investigating the Link Between Semaglutide and Suicidal Ideation

June 21st 2024

Recent research found approximately 60 documented cases of suicidal ideation and 7 suicide attempts associated with semaglutide use in patients.

A Brief Cannabis Cessation Protocol to Increase Patient Motivation

June 20th 2024

How to Safely and Effectively Taper Benzodiazepines

June 19th 2024

New Baseline Data on Iclepertin for Schizophrenia

June 18th 2024

Insights and Explorations

June 17th 2024

Latest Videos
© 2024 MJH Life Sciences

All rights reserved.